Clinical trial Recruiting at 1 site Interventional Ages 40 to 70

Eccentric gastrocnemius strengthening vs low-load blood flow restriction training for knee osteoarthritis

Official title: Comparison of Eccentric and Low-Load Blood Flow Restriction Training on Neuromuscular Adaptations in Knee Osteoarthritis

Run by Riphah International University · NCT07733518 · Data updated 2026-11-12

This study tests whether eccentric strengthening of the calf muscle or low-load blood flow restriction training can improve strength and function in people with knee osteoarthritis.

Quick facts

Study typeInterventional
Ages40 Years to 70 Years
SexAll
Enrollment48 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Rawalpindi, Punjab Province)
StatusRecruiting
StartedJuly 21, 2026
Main results expectedDecember 21, 2026
Study endsDecember 28, 2026
Registry record updatedAugust 7, 2026
Trial IDNCT07733518 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40-70 with clinical knee OA (Kellgren-Lawrence grades 1-3), adequate pain control (3/10 or less), able to ambulate independently, and with gastrocnemius strength of at least 3/5.

Probably not a fit

Participants with prosthetic knees, inflammatory arthritis, or cardiovascular/pulmonary conditions that limit safe exercise may not benefit from the interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two exercise approaches for knee osteoarthritis: eccentric gastrocnemius strengthening and low-load blood flow restriction training. Eligible adults aged 40-70 with symptomatic knee OA (Kellgren-Lawrence grades 1-3) and sufficient pain and strength will participate under supervised conditions. Outcomes focus on neuromuscular adaptations, muscle strength, functional performance, and disability to see which method better supports daily movement. The trial is conducted at Railway General Hospital in Rawalpindi with Riphah International University as the lead sponsor. Safety screenings exclude individuals with prosthetic knees, inflammatory arthritis, or cardiovascular, pulmonary, or clotting contraindications to exercise.

Why it matters

Potential benefit: If successful, the trial could identify which training approach better improves knee function and quality of life for people with knee OA.

How similar studies have gone: Prior research supports neuromuscular and strength adaptations from targeted calf and restricted-blood-flow training in musculoskeletal populations, but this exact comparison in knee OA is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age group 40-70
* Both genders male and female
* Clinical diagnosis of knee OA (Kellgren-Lawrence grade 1-3) of the most symptomatic knee.
* Pain stable enough to permit exercise on Numeric Pain Rating Scale 3/10.
* Participants must demonstrate a gastrocnemius muscle strength of grade ≥3 on the Manual Muscle Testing (MMT) scale (0-5), assessed using the standard standing heel-rise position.
* Participants must be able to ambulate independently and participate in supervised exercise.

Exclusion Criteria:

* • Presence of a prosthetic knee in the affected limb.

  * Inflammatory arthritis (e.g., rheumatoid arthritis) or active flare-up of OA.
  * Cardiovascular disease contraindicating exercise (e.g., unstable angina, recent MI, uncontrolled hypertension ≥160/100 mmHg).
  * Pulmonary disease that limits safe participation (e.g., severe COPD, recent exacerbation).
  * History of deep vein thrombosis (DVT), peripheral vascular disease, or bleeding/clotting disorders.
  * Current anticoagulant therapy that increases bleeding risk (unless cleared by physician).
  * Any pathology causing significant muscle weakness (e.g., neuromuscular disorders, severe neuropathy).

Where it's running

  • Railway General Hospital, Rawalpindi
    Rawalpindi, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.